Heart failure with preserved ejection fraction as an interdisciplinary problem
Przegląd Lekarski – Jagiellonian Medical Review · 2025
DOI: 10.20452/jmr.2025.17944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Przegląd Lekarski – Jagiellonian Medical Review, 2025. Verfasst von Patrycja Mołek‑Dziadosz und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
REVIEW HFpEF as an interdisciplinary problem 1 filling pressures and clinical symptoms such as dyspnea, fatigue, and exercise intolerance.2 HFpEF is closely linked to several metabolic and cardiovascular disorders, including type 2 diabetes mellitus (T2DM), hypertension, obesity, and atrial fibrillation (AF).T2DM promotes myocardial fibrosis, endothelial dysfunction, and systemic inflammation, all of which contribute to the pathogenesis of HFpEF. 3 Hypertension is a major driver of LVH and arterial stiffness, exacerbating diastolic dysfunction and increasing the likelihood of HFpEF development.4 Obesity, particularly central adiposity, is associated with increased myocardial workload, inflammation, and altered cardiac metabolism, further predisposing individuals to HF-pEF. 5 AF, frequently observed in patients with HFpEF, worsens diastolic dysfunction by causing tachycardia -induced cardiomyopathy and a
Zitieren
APA
Mołek‑Dziadosz, P., & Nessler, J. (2025). Heart failure with preserved ejection fraction as an interdisciplinary problem. Przegląd Lekarski – Jagiellonian Medical Review. https://doi.org/10.20452/jmr.2025.17944
Vancouver
Mołek‑Dziadosz P, Nessler J. Heart failure with preserved ejection fraction as an interdisciplinary problem. Przegląd Lekarski – Jagiellonian Medical Review. 2025. doi:10.20452/jmr.2025.17944
BibTeX
@article{MoekDziadosz2025,
author = {Mołek‑Dziadosz, Patrycja and Nessler, Jadwiga},
title = {Heart failure with preserved ejection fraction as an interdisciplinary problem},
journal = {Przegląd Lekarski – Jagiellonian Medical Review},
year = {2025},
doi = {10.20452/jmr.2025.17944}
}
EUVIMED